Abstract
Since gangliosides are found in the plasma membranes of numerous cell types and interact with apparent specificity with a number of different agents such as toxins, antibodies, and hormones, it is reasonable to regard them as receptor molecules. Our interest in ganglioside receptors stems from their reactions with antibodies. Gangliosides represent only one class of molecules in vertebrate synapses that can be identified as functional components through perturbation of CNS functions by intracerebral administration of antibodies. Since gangliosides are relatively small, stable molecules whose chemistry has been well established, they provide a better focus than other antigenic components of the synapse for developing methods to detect and identify functional molecules. GM1 ganglioside may be especially useful for this purpose since, of the various ganglioside species present in the synaptic membrane, more of the GM1 is exposed on the outer surface and is therefore access-ible to antibodies in the extracellular space.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
RAPPORT, M.M. and MAHADIK, S.P. (1977): Topographic studies of glycoproteins and gangliosides in synaptosomes in “Mechanisms of Regulation and Special Functions of Protein Synthesis in the Brain” Roberts et al. eds. Elsevier, New York, pp. 221–230.
RAPPORT, M.M. and KARPIAK, S.E. (1978): Immunological perturbation of neurological functions in “Senile Dementia” Nandy, K. ed., Elsevier, North Holland, New York, pp. 73–88.
KARPIAK, S.E., GRAF, L., AND RAPPORT, M.M. (1976): Antiserum to brain gangliosides produces recurrent epileptiform activity. Science 194, 735–737.
KARPIAK, S., SOWIN, T., and RAPPORT, M.M. (1977): Antiserum to brain gangliosides inhibits consolidation phases of learning. Neurosci. Abstr. 3, 236.
RAPPORT, M.M., KARPIAK, S.E., KASARSKIS, E.J. and BASS, N.H. (1979): Behavioral changes after perinatal exposure to anti-GM1 ganglioside. Trans. Am. Soc. Neurochem. 10, 234.
KASARSKIS, E.J., KARPIAK, S.E., RAPPORT, M.M., and BASS, N.H. (1979): Abnormal cortical maturation after neonatal anti-GM1 ganglioside exposure. Trans. Am. Soc. Neurochem. 10, 233.
KARPIAK, S.E., BODNAR, R.J., HANSON, S., GLUSMAN, M., and RAPPORT, M.M. (1978): Antibodies to GM1 ganglioside block morphine analgesia. Neurosci. Abstr. 4, 460.
HESS, H.H. and POPE, A. (1972): Quantitative neurochemical histology in “Handbook of Neurochemistry” Lajtha, A. ed., Plenum, New York Vol. VII, pp. 289–329.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Press, New York
About this chapter
Cite this chapter
Rapport, M.M., Karpiak, S.E., Mahadik, S.P. (1980). Perturbation of CNS Functions by Antibodies to Gangliosides. Speculations on Biological Roles of Ganglioside Receptors. In: Svennerholm, L., Mandel, P., Dreyfus, H., Urban, PF. (eds) Structure and Function of Gangliosides. Advances in Experimental Medicine and Biology, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7844-0_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7844-0_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7846-4
Online ISBN: 978-1-4684-7844-0
eBook Packages: Springer Book Archive